KIF20A promotes the development of fibrosarcoma via PI3K-Akt signaling pathway.

Zheng Jin, Shuang Tao, Chao Zhang, Damo Xu, Zhenhua Zhu

Experimental cell research 2022 Nov 01

filter terms:

Adult fibrosarcoma is an aggressive subtype of soft tissue sarcoma (STS), in which high expression of KIF20A indicates a poor prognosis. However, the precise role of KIF20A in fibrosarcoma progression remains unknown. In this study, we initially examined KIF20A expression and function in the human fibrosarcoma cell line HT-1080. The results showed that KIF20A was highly expressed in HT-1080, knockdown of KIF20A impaired cell proliferation, migration, invasion and induced G2/M arrest and cell apoptosis. Transcriptome study suggested that PI3K-Akt signal pathway was involved in these biological changes. We confirmed that PI3K-Akt and NF-κB signaling pathways were impaired after the down-regulation of KIF20A, which can be reversed by the Akt activator SC79 in HT-1080 in vitro. In a xenograft mouse model, knockdown of KIF20A inhibited tumor growth, Ki67 expression and liver metastasis. Taken together, our results suggested that KIF20A promoted fibrosarcoma progression via PI3K-Akt signaling pathway and might be a potential therapeutic target for fibrosarcoma. Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Citation

Zheng Jin, Shuang Tao, Chao Zhang, Damo Xu, Zhenhua Zhu. KIF20A promotes the development of fibrosarcoma via PI3K-Akt signaling pathway. Experimental cell research. 2022 Nov 01;420(1):113322